UK Government strategy to back pharma falling on deaf ears

Efforts unveiled by the UK government to promote the life sciences sector post-Brexit have yet to capture the attention of industry executives. Having unveiled the findings of a new survey at BIO-Europe Spring, IQVIA market development director Angela McFarlane discussed with Scrip the challenges ahead.